RX-10008

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRX-10008
Drug Alias NameRX-10008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInflammation mediator inhibitorsLipid modulators
TargetsNot applicable
Therapy Area/IndicationsMacular DegenerationXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesResolvyx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesResolvyx
Active IndicationsN/A
Inactive IndicationsMacular DegenerationXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A